Tempura/E+ via Getty Images
Here We Go
Today we write about one of the most hotly contested REITs in the market today--Medical Properties Trust (NYSE:MPW), a healthcare REIT that has become a battleground of sorts for bulls and
Medical Properties Trust: A Deteriorating Picture
Summary
- Medical Properties Trust, a healthcare REIT, has seen its stock fall by more than 50% since January 2022.
- The company's Q1 2023 report showed a decrease in rent billed and straight-line rent, an increase in total expenses.
- The outstanding share count at Medical Properties has risen by over 250% in the last ten years.
Looking for value, or lack thereof, throughout the market. Long by nature, short by necessity, generally contrarian.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Disclaimer: The information contained herein is opinion and for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Factual errors may exist and will be corrected if identified. The opinion of the author may change at any time and the author is under no obligation to disclose said change. Nothing in this article should be construed as personalized or tailored investment advice. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal, and readers should not utilize anything in our research as a sole decision point for transacting in any security for any reason.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.